Enhancement of oral bioavailability of insulin in humans

Neuroendocrinology Letters

Volumn 30, Issue 1, 2009, Pages 74-78

  Badwan, Adnan ^a   Remawi, Mayas ^a   Qinna, Nidal ^a,d   Elsayed, Amani ^a,e   Arafat, Tawfiq ^b   Melhim, Munther ^b   Hijleh, Omar Abu ^c   Idkaidek, Nasir M ^d,e  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b Jordan Center for Pharmaceutical Research Amman   (Jordan)

^c Jordan Center for Diabetes and Endocrinology   (Jordan)

^d UNIVERSITY OF PETRA   (Jordan)

^e UNIVERSITY OF GEZIRA   (Sudan)

Author keywords

Dimensional analysis; In Silico; Insulin; Intestinal permeability; Oral absorption; Simulation

Indexed keywords

INSULIN; ISOPHANE INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PARTICLE SIZE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INTESTINAL ABSORPTION; MALE; NANOPARTICLES; REFERENCE STANDARDS; YOUNG ADULT;

EID: 65349142019     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. American Diabetes Association (1998). Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 21: 2180-2184.
2. Taylor DC, Pownal RI and Burke W (1985). The absorption of -adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity. J. Pharm. Pharmacol. 37: 280-283.
3. DeFronzo RA, Tobin JD, Andres R (1979). Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 237: E214-E223.
4. Lennernäs H, Ahrenstedt Ö and Ungell AL (1994). Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. Br. J. clin. Pharmac. 37: 589-596.
5. Lennernäs H, Ahrenstedt Ö, Hällgren R, Knutson L, Ryde M and Paalzow LK (1992). Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharmaceutical Research. 9: 1243-1251.
6. Ewe K, Wanitschke R, Staritz M (1994). Intestinal permeability studies in humans. In. T. Z. Csaky (eds.), Pharmacology of Intestinal Permeation II, Springer-Verlag, New York. 535-571.
7. Kinetica manual, Version 4.1, Innaphase Co., France, 2000.
8. Lauritzen • T, Zoffmann V (2004). Understanding the psychological barriers to effective diabetes therapy. Diabetes Voice. 49: 16-18.
9. Modigliani R, Rambaud JCand Bernier JJ (1973). The method of intraluminal perfusion of the human small intestine. I. Principle and technique. Digestio. 9: 176-192
10. • manual (2007), Version 7.11, SIMCYP Ltd, UK.
11. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes. (1996) 45: 1289-1298.
12. Csaky TZ (1984). Intestinal permeation and permeability: an overview. In. Csaky TZ (eds.), Pharmacology of Intestinal Permeation I, Springer-Verlag, New York. 51-59.